A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.

@article{Reekie2011ACO,
  title={A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.},
  author={Joanne Reekie and Peter Reiss and Bruno Ledergerber and Dalibor Sedl{\'a}{\vc}ek and Miłosz Parczewski and J. M. Gatell and Christine Katlama and Gerdt F{\"a}tkenheuer and Jens D. Lundgren and Amanda Mocroft},
  journal={HIV medicine},
  year={2011},
  volume={12 5},
  pages={259-68}
}
OBJECTIVES The durability of combination antiretroviral therapy (cART) regimens can be measured as time to discontinuation because of toxicity or treatment failure, development of clinical disease or serious long-term adverse events. The aim of this analysis was to compare the durability of nevirapine, efavirenz and lopinavir regimens based on these measures. METHODS Patients starting a nevirapine, efavirenz or lopinavir-based cART regimen for the first time after 1 January 2000 were included… CONTINUE READING
13 Citations
29 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Similar Papers

Loading similar papers…